Skip to main content
QNCX
NASDAQ Life Sciences

Quince Therapeutics Posts $35.9M Q1 Profit, Reversing Prior Going Concern Doubts

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.26
Mkt Cap
$20.213M
52W Low
$0.8
52W High
$45.499
52W Position info
57% above low
Off High info
97% below high
Rel. Volume
Market data snapshot near publication time

QNCX sits 57% above its 52-week low of $0.8.

Summary

Quince Therapeutics reported a significant financial turnaround in Q1 2026, posting a net income of $35.9 million and diluted EPS of $2.88. This marks a dramatic swing from a net loss of $15.0 million in the prior year's quarter. The profitability comes after the company halted development of its lead drug, eDSP, following a Phase 3 trial failure, leading to substantial reductions in R&D and trial costs. This positive financial performance directly addresses the 'going concern' warning issued in the company's recent 10-K filing on April 10, which had raised doubts about its long-term viability. For traders, this unexpected profitability fundamentally alters the risk profile and investment thesis for the micro-cap company. Investors will now watch for updates on the company's strategic review, including its pursuit of a potential reverse merger and efforts to secure future financing.

At the time of this announcement, QNCX was trading at $1.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.2M. The 52-week trading range was $0.80 to $45.50. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

QNCX - Latest Insights

QNCX
Oct 09, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $31.00
Real-time Price: $31.73 info
Change: +$0.730 (+2%) info
Market Cap: $32.271M info
QNCX
Oct 09, 2026, 7:59 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $29.36
Real-time Price: $31.73 info
Change: +$2.37 (+8%) info
Market Cap: $32.271M info
QNCX
Oct 06, 2026, 4:57 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.81
Real-time Price: $31.73 info
Change: +$4.92 (+18%) info
Market Cap: $32.271M info
QNCX
Sep 14, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.59
Real-time Price: $31.73 info
Change: +$3.14 (+11%) info
Market Cap: $32.271M info
QNCX
Sep 04, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $30.55
Real-time Price: $31.73 info
Change: +$1.18 (+4%) info
Market Cap: $32.271M info